› Forums › General Melanoma Community › MEK Trial for Brent
- This topic has 22 replies, 3 voices, and was last updated 13 years, 12 months ago by Jim in Denver.
- Post
-
- December 13, 2010 at 5:06 pm
Hi everyone,
Brents scans this past last week, after 9 months, where mixed. Some measured a tiny bit larger than 2 months ago, but not as big as the baseline scan from February. His doctor did not take him off the trial, for which he was grateful, saying there is not significant growth. Yesterday he is telling me he has some strange (discomfort in the lung area near where the growth was measured to be the most). He will be scanned again in February.
Hi everyone,
Brents scans this past last week, after 9 months, where mixed. Some measured a tiny bit larger than 2 months ago, but not as big as the baseline scan from February. His doctor did not take him off the trial, for which he was grateful, saying there is not significant growth. Yesterday he is telling me he has some strange (discomfort in the lung area near where the growth was measured to be the most). He will be scanned again in February.
We are looking into the plan B for the next treatment. He was retested for a whole list of mutations and is negative. The NRAS and GNAQ results are still not available. He was Braf negative when he went on the trial. The arm of that trial he started in Feb. was for solid tumors and he did not have to be Braf positive to begin treatment.
He feels fantastic, great appetite, high energy, and no real pain to speak of. His breathing is good also.
We know that CT scans can show different things at different times and are not perfect. This could account for the difference from this scan to last.
We also know that most trials require that you not have previous treatment with inhibiitors. I am aware that it is not going to be easy to move onto the next treatment and want to have some options in mind aheard of the game.
Anyone out there who has failed a MEK inhibitor and has moved on to another trial? Your input and feedback would be greatly appreciated.
God Bless you all.
Sharon and Brent
- Replies
-
-
- December 13, 2010 at 8:23 pm
So sorry about your news.
What are your doctors recommending for plan B? How about IPI?
Stay strong..Brent is a fighter!
-
- December 13, 2010 at 8:33 pm
Hi Sharon,
You and Brent would probably next consider a systemic treatment if the targeted treatment is not helping. I am sure others will make the same observation. That would mean ipilimab for "Plan B" and maybe IL2 or biochemo for "Plan C".
Best Wishes,
Jim
-
- December 13, 2010 at 8:33 pm
Hi Sharon,
You and Brent would probably next consider a systemic treatment if the targeted treatment is not helping. I am sure others will make the same observation. That would mean ipilimab for "Plan B" and maybe IL2 or biochemo for "Plan C".
Best Wishes,
Jim
-
- December 13, 2010 at 8:36 pm
I forgot about MDX 1105 or Anti PD1 as a possible Plan B as well, but that would be a Phase I Trial. Here is more info:
-
- December 13, 2010 at 8:36 pm
I forgot about MDX 1105 or Anti PD1 as a possible Plan B as well, but that would be a Phase I Trial. Here is more info:
-
- December 13, 2010 at 9:03 pm
Sharon:
Not thinking clearly today – I meant to say MDX 1106. Since Brent is currently being treated at MDA, your Oncologist there can tell you if he would be eligible for the Ipi + Temador Trial in which I am participating. It is one of a few Ipi combination trials and is available only at MDA., so it would make sense to ask about it. Researh into MDX 1106 is not as far along as with Ipi (also known as MDX 010 – both owned by Bristol Meyers), but it looks very promising, expecially in combination with Ipi, but it is available only at Yale Univ and MSK in NYC. I see that Brent has already had biochemo, so that would maybe leave IL2 as another option.
Best,
Jim
-
- December 13, 2010 at 9:44 pm
Yes you are correct, so these two treatment options would be mutually exclusive. You obviously are up to speed on your options, so my comments are probably not helpful. Has Brent already received Ipi? If not, you might ask your Doc at MDA about both the Ipi+Temador as well as Compassionate Use Ipi. Of course, Ipi trials will stop once the FDA apprives "Yervoy" (late March?), and then the decision about whether it is an option will be up to you and your insurance company.
Best Wishes
Jim
-
- December 13, 2010 at 9:44 pm
Yes you are correct, so these two treatment options would be mutually exclusive. You obviously are up to speed on your options, so my comments are probably not helpful. Has Brent already received Ipi? If not, you might ask your Doc at MDA about both the Ipi+Temador as well as Compassionate Use Ipi. Of course, Ipi trials will stop once the FDA apprives "Yervoy" (late March?), and then the decision about whether it is an option will be up to you and your insurance company.
Best Wishes
Jim
-
- December 13, 2010 at 9:03 pm
Sharon:
Not thinking clearly today – I meant to say MDX 1106. Since Brent is currently being treated at MDA, your Oncologist there can tell you if he would be eligible for the Ipi + Temador Trial in which I am participating. It is one of a few Ipi combination trials and is available only at MDA., so it would make sense to ask about it. Researh into MDX 1106 is not as far along as with Ipi (also known as MDX 010 – both owned by Bristol Meyers), but it looks very promising, expecially in combination with Ipi, but it is available only at Yale Univ and MSK in NYC. I see that Brent has already had biochemo, so that would maybe leave IL2 as another option.
Best,
Jim
-
- You must be logged in to reply to this topic.